Vote the WHITE proxy card today!
The election of each of the Company’s highly qualified Board nominees: Dr. M. Kathleen Behrens, K. Todd Newton, Timothy R. Wright and Dr. Phyllis Gardner
Advisory approval of executive compensation
Ratification of Auditors
To declassify the board of directors of the Company
To reduce ownership threshold to call a special shareholders’ meeting
To adopt proxy access
If you have any questions or require any assistance with respect to voting your shares, please contact our proxy solicitor:
Toll Free: (800) 662-5200 or at (203) 658-9400
MIMEDX will hold its 2021 Annual Meeting of Shareholders on Thursday, May 27, 2021, at 10:00 a.m. Eastern Time. The meeting will be held in virtual format only at www.cesonlineservices.com/mdxg21_vm. The Board has fixed 5:00 p.m. Eastern Time on April 16, 2021 as the record date for shareholders who will be entitled to vote at the Annual Meeting.
Under a refreshed Board of Directors and senior management team, MIMEDX is executing on a strategy and is driving enhanced shareholder value following a deeply tumultuous period in the Company’s history. Over the course of 2020, MIMEDX successfully implemented a number of governance, operational and financial initiatives that were critical to restoring the Company’s integrity, improving business liquidity, and transforming the culture of the organization.
The investments we are making in people, resources, and strategic initiatives will also position us to accelerate our late-stage pipeline and achieve our stated top line growth objectives in our core business.
The MIMEDX Board is made up of nine talented, experienced and highly engaged directors who are strongly committed to acting in the best interest of all MIMEDX shareholders. The entire Board is confident that the Company is on the right path forward. The significant progress we made in 2020 has created a strong foundation for growth in 2021 and beyond. We look forward to continuing to execute on our current strategy and create long-term shareholder value.
The Board unanimously recommends that shareholders vote the WHITE proxy card FOR the Company’s experienced and highly qualified director nominees.